• Nenhum resultado encontrado

Radioterapia estereotáxica extracraniana em câncer de pulmão: atualização.

N/A
N/A
Protected

Academic year: 2017

Share "Radioterapia estereotáxica extracraniana em câncer de pulmão: atualização."

Copied!
12
0
0

Texto

Loading

Imagem

Figura 1 - Processo do tratamento com  stereotactic body radiation therapy  e os principais aspectos de
Tabela 1 - Séries reportando resultados clínicos em lesões pulmonares periféricas tratadas com  stereotactic
Tabela 2 - Resultados clínicos do uso de  stereotactic body radiation therapy  em lesões centrais.
Tabela 3 - Toxicidade relacionada à  stereotactic body

Referências

Documentos relacionados

Objectives: To determine differences in overall survival and quality of life among patients with stage IV non-small cell lung cancer non-metastatic to the brain treated with

Long-term Results of RTOG 0236: A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Medically Inoperable Stage I Non-Small Cell

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase III trial in regionally advanced, unresec-

Prognostic significance of metastases to mediastinal lymph node levels in resected non small cell lung carcinoma.. Surgery for stage IIIA-N2 non small cell

rad i otherapy followed by surgery for stages III A (N2) and III B non-small-cell lung cancer: mature results of Southwest.. Oncology Group phase II study

Survival and prognostic factors in patients with Non-Small Cell Lung Cancer treated in private health care.. Sobrevida e fatores prognósticos em pacientes com câncer de pulmão de

In a previous study of cases of stage I non-small cell lung cancer (NSCLC), we also reported significant gender-related differences in long-term survival, with better rates

Non-Hodgkin’s lymphoma of the brain: Can high dose large volume radiation therapy improve sur- vival. Report on a prospective trial by the Radiation Therapy Oncology Group